Skip to main content
. 2020 Apr 6;20:153. doi: 10.1186/s12888-020-02568-2

Table 2.

Clinic outcome scores: change from baseline during rTMS treatment for overall study population

Baseline Day 5 Day 30 Day 60 Day 90
PSQIa 9.24 (3.89) 5.09 (3.33) 5 (3.13) 5.28 (3.47) 6.12 (3.32)
Change from Baseline −4.15 (0.53) * −4.24 (0.58) * −3.96 (0.67) * −3.12 (0.66) *
CCQb 12.67 (10.93) 2.21 (3.29) 1.34 (2.79) 1.84 (4) 3.8 (6.5)
Change from Baseline −10.45 (1.15) * −11.32 (1.20) * − 10.81 (1.41) * −8.86 (1.38) *
BDI-IIc 18.99 (9.91) -§ 5.09 (6.45) 5.33 (7.67) 6.72 (7.2)
Change from Baseline −13.89 (1.38) * −13.65 (1.64) * − 12.26 (1.58) *
SASd 47.93 (10.01) 36.11 (8.45) 35.97 (9.44) 35.33 (9.52) 38.09 (7.38)
Change from Baseline −11.81 (2.04) * −11.96 (1.54) * −12.60 (1.87) * −9.83 (1.77) *
GSIe 65.91 (16.53) 46.69 (12.17) 47.67 (14.46) 44.49 (10.92) 46.46 (9.56)
Change from Baseline −19.22 (2.08) * −18.24 (2.25) * −21.42 (2.67) * −19.45 (2.59) *

Data are presented as Mean (SD);

* p value <.001; § BDI-II was not administered at day 5 because it refers to the last 2 weeks;

a Pittsburgh Sleep Quality Inventory – general sleep quality index; b Cocaine Craving Questionnaire; c Beck Depression Inventory – II; d Self-rating Anxiety Scale;

e Global Severity Index from Symptoms Checklist – 90 – Revised